Keyphrases
Genetic Variants
100%
Type 2 Diabetes Risk
100%
Genetic Risk
100%
Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9)
100%
Mendelian Randomization
100%
Fasting Plasma Glucose
60%
Waist-to-hip Ratio
60%
PCSK9 Inhibitors
60%
Type 2 Diabetes Mellitus (T2DM)
40%
Hemoglobin A1c (HbA1c)
40%
Fasting Insulin
40%
LDL Cholesterol
40%
Low LDL Cholesterol
40%
Meta-analysis
20%
Statin Therapy
20%
Hyperglycemia
20%
Randomized Controlled Trial
20%
Coronary Artery Disease
20%
Statins
20%
Diabetes Risk
20%
Safety Outcomes
20%
Odds Ratio
20%
Glucose Concentration
20%
Combined Analysis
20%
London Hospital
20%
Pre-analysis Plan
20%
Inhibitor Drug
20%
HMG-CoA Reductase
20%
Biomedical Research Centres
20%
British Heart Foundation
20%
National Institute for Health Research
20%
Standardized Analysis
20%
University College London
20%
Type Diabetes
20%
NHS Trusts
20%
Inhibitor Treatment
20%
LDL-cholesterol Lowering
20%
Medicine and Dentistry
Maturity Onset Diabetes of the Young
100%
Genetic Risk
100%
Mendelian Randomization Analysis
100%
Genetic Variability
100%
Low Density Lipoprotein Cholesterol
83%
Hip
50%
Diabetes
33%
Statin
33%
Hemoglobin A1c
33%
Body Mass Index
33%
Biological Marker
16%
Cohort Analysis
16%
Randomized Controlled Trial
16%
Ischemic Heart Disease
16%
Meta-Analysis
16%
Hyperglycemia
16%
Odds Ratio
16%
Biomedical Research
16%
Hydroxymethylglutaryl Coenzyme A Reductase
16%
Blood Glucose
16%
Case-Control Study
16%